In 2014, MAPS spun out a independent division to direct investigation and prepare for an eventual FDA application, which it submitted at the end of past year. In early 2024, that offshoot was renamed Lykos Therapeutics.Congratulations in the event you’ve read through this considerably and you think you may well be hooked on copyright crystal or o